English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

FMC Corporation announces first quarter 2021 results in line with expectations and maintains strong full-year growth outlookqrcode

May. 6, 2021

Favorites Print
Forward
May. 6, 2021

FMC Corporation
United States  United States
Follow

First Quarter 2021 Highlights


  • Revenue of $1.2 billion, a decrease of 4 percent versus Q1 2020 and down 5 percent organically1

  • Consolidated GAAP net income of $183 million, down 11 percent versus Q1 2020

  • Adjusted EBITDA of $307 million, down 14 percent versus Q1 2020

  • Consolidated GAAP earnings of $1.40 per diluted share, down 11 percent versus Q1 2020

  • Consolidated adjusted earnings per diluted share of $1.53, down 17 percent versus Q1 2020

  • Share repurchases of $75 million


Full-Year Outlook2


  • Maintains revenue forecast in the range of $4.9 to $5.1 billion, reflecting 8 percent growth at the midpoint versus 2020

  • Maintains adjusted EBITDA forecast in the range of $1.32 to $1.42 billion, reflecting 10 percent growth at the midpoint versus 2020

  • Raises 2021 adjusted earnings forecast to a range of $6.70 to $7.40 per diluted share, reflecting 14 percent growth at the midpoint versus 2020, excluding any impact from future share repurchases

  • Maintains free cash flow forecast in the range of $530 to $620 million, reflecting 6 percent growth at the midpoint versus 2020

  • Continues to expect to repurchase $400 to $500 million of FMC shares in 2021


FMC Corporation (NYSE:FMC) reported first quarter 2021 revenue of $1.2 billion, a decrease of 4 percent versus first quarter 2020. Excluding a slight tailwind from foreign currencies, revenue declined 5 percent organically. On a GAAP basis, the company reported earnings of $1.40 per diluted share in the first quarter, a decrease of 11 percent versus first quarter 2020. First quarter adjusted earnings were $1.53 per diluted share, a decrease of 17 percent versus first quarter 2020.

QQ截图20210506092440.png

"Our first quarter financial results were largely as anticipated; we delivered revenue at the high end and earnings slightly above the midpoint of our guidance ranges," said Mark Douglas, FMC president and chief executive officer.   

FMC revenue decline was driven by a 4 percent volume decline, with a 1 percent FX tailwind offsetting a 1 percent price headwind. Asia grew revenue 18 percent (up 13 percent organically) driven by strong demand for the recently launched Overwatch® herbicide in Australia and diamide demand across the region. Sales in EMEA declined 4 percent (down 8 percent organically) driven by Brexit-related orders in Q4 2020 and discontinued registrations, offset partially by increased insecticide sales. In North America, a double-digit sales increase for herbicides and a strong product launch of Xyway fungicide were more than offset by a shift of diamide third-party partner sales from North America to Latin America which led to an 8 percent decline in the region. In Latin America, revenue declined 22 percent (down 13 percent organically), driven by our proactive channel inventory management as well as reduced cotton planting and FX headwinds.

QQ截图20210506092448.png

FMC first quarter adjusted EBITDA was $307 million, a decrease of 14 percent from the prior-year period. This decrease was driven primarily by cost increases on raw materials and higher R&D spending, as well as volume declines in Latin America and EMEA.  These were offset partially by new product launches in Asia and North America.

2021 and Second Quarter Outlook2

The company continues to forecast full-year 2021 revenue to be in the range of $4.9 billion to $5.1 billion, driven by growth in all regions and representing an 8 percent increase at the midpoint versus 2020.  The revenue growth will be driven primarily by volume, as well as price increases.  Foreign currencies are not expected to impact full-year sales.  Full-year adjusted EBITDA is still expected to be in the range of $1.32 billion to $1.42 billion, representing 10 percent year-over-year growth at the midpoint.  2021 adjusted earnings are now expected to be in the range of $6.70 to $7.40 per diluted share, representing a year-over-year increase of 14 percent at the midpoint.  This is an increase of 5 cents at the midpoint versus prior guidance, reflecting the lower share count resulting from $75 million in share repurchases in the first quarter.

Full-year earnings growth drivers include strong volume growth led by Asia, Latin America and North America.  Broad-based price increases are forecast across the globe.  Full-year free cash flow is still expected to be $530 to $620 million, representing a 6 percent increase year-over-year.  The company continues to expect to repurchase $400 to $500 million of FMC shares in 2021, including the $75 million of shares repurchased in Q1.

Second quarter revenue is expected to be in the range of $1.19 billion to $1.26 billion, representing an increase of 6 percent at the midpoint compared to second quarter 2020.  Adjusted EBITDA is forecast to be in the range of $330 million to $360 million, representing a 1 percent increase at the midpoint versus Q2 2020. FMC expects adjusted earnings per diluted share to be in the range of $1.68 to $1.88 in the second quarter, an increase of 3 percent at the midpoint versus Q2 2020.

"We are forecasting increased raw material and logistics costs in the second quarter offset by strong demand and a modest FX tailwind," said Douglas. "We expect much of the growth in 2021 to be in the second half, driven by strong volume, new product launches and improved pricing."

QQ截图20210506092457.png


Supplemental Information

The company will post supplemental information on the web at https://investors.fmc.com, including its webcast slides for tomorrow's earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the nearest available GAAP term.


  1. Organic revenue growth (non-GAAP) excludes the impact of foreign currency changes.

  2. Although we provide forecasts for adjusted earnings per share and adjusted EBITDA (non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no GAAP outlook is provided.

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox